AnalyzeDirect

Hockaday DC, Shen S, Fiveash J, Raubitschek A, Colcher D, Liu A, Alvarez V, Mamelak AN. Imaging glioma extent with ¹³¹I-TM-601. J Nucl Med. April 2005;46(4):580-586.

Full Text – Open Access

Publication Date
April 2005

How Analyze was Used
“All image analysis was performed with Analyze 5.0 software (AnalyzeDirect).”

Keywords
Adult
Brain/metabolism/radionuclide imaging
Brain Neoplasms/metabolism/radionuclide imaging
Feasibility Studies
Female
Glioma/metabolism/radionuclide imaging
Humans
Male
Metabolic Clearance Rate
Organ Specificity
Radiopharmaceuticals/diagnostic use/pharmacokinetics
Reproducibility of Results
Scorpion Venoms/diagnostic use/pharmacokinetics
Sensitivity and Specificity
Tissue Distribution

Author Affiliation(s)
Neurosurgery Section, Department of General and Oncological Surgery, City of Hope Cancer Center, Duarte, CA, US. (DCH, ANM)

Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, AL, US. (SS, JF)

Department of Radio-Immunotherapy, Beckman Research Institute, City of Hope Cancer Center, Duarte, CA, US. (AR, DC, AL)

Transmolecular, Inc., Birmingham, AL, US. (VA)

ID# 2024

Tags: Adult, Brain Neoplasms/metabolism/radionuclide imaging, Brain/metabolism/radionuclide imaging, Feasibility Studies, Female, Glioma/metabolism/radionuclide imaging, Humans, Male, Metabolic Clearance Rate, Organ Specificity, Radiopharmaceuticals/diagnostic use/pharmacokinetics, Reproducibility of Results, Scorpion Venoms/diagnostic use/pharmacokinetics, Sensitivity and Specificity, Tissue Distribution